GFA
Gallagher Fiduciary Advisors Portfolio holdings
AUM
$2.58B
This Quarter Return
-0.18%
1 Year Return
+5.01%
3 Year Return
+76.76%
5 Year Return
+89.63%
10 Year Return
+23.3%
AUM
$511M
AUM Growth
+$511M
(+3.5%)
Cap. Flow
+$22.8M
Cap. Flow
% of AUM
4.47%
Top 10 Holdings %
Top 10 Hldgs %
42.4%
Holding
307
New
33
Increased
215
Reduced
36
Closed
9
Top Buys
| 1 |
Vanguard Growth ETF
VUG
|
$6.16M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
$2.9M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
$1.85M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$1.5M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
$1.33M |
Top Sells
Sector Composition
| 1 | Technology | 4.43% |
| 2 | Financials | 4.14% |
| 3 | Consumer Discretionary | 3.02% |
| 4 | Industrials | 2.24% |
| 5 | Communication Services | 2.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Solventum
SOLV
$12.4B
| – | – |
-2,967
| Closed | -$207K |
|
302
Stanley Black & Decker
SWK
$11.3B
| – | – |
-2,027
| Closed | -$223K |
|
303
Regeneron Pharmaceuticals
REGN
$59.8B
| – | – |
-263
| Closed | -$276K |
|
304
Novo Nordisk
NVO
$252B
| – | – |
-1,858
| Closed | -$221K |
|
305
Fastenal
FAST
$56.8B
| – | – |
-4,281
| Closed | -$306K |
|
306
ASML
ASML
$290B
| – | – |
-241
| Closed | -$201K |
|
307
Anika Therapeutics
ANIK
$130M
| – | – |
-8,809
| Closed | -$218K |
|